[Management of new oral anticoagulants in gastrointestinal bleeding and endoscopy]

Abstract

New oral direct anticoagulants agents are alternatives to warfarin for long-term anticoagulation in a growing number of patients that require long-term anticoagulation for atrial fibrillation, deep venous thrombosis and pulmonary embolism. These new agents with predictable pharmacokinetic and pharmacodynamics profiles offer a favorable global safety profile, but increased gastrointestinal bleeding compared to the vitamin K antagonists. Many gastroenterologists are unfamiliar and may be wary of these newer drugs, since Clinical experience is limited and no specific antidote is available to reverse their anticoagulant effect. In this article the risk of these new agents and, how to manage these agents in both the presence of acute gastrointestinal bleeding and in patients undergoing endoscopic procedures is reviewed.

Keywords: Anticoagulación oral; Anticoagulantes orales directos; Direct oral anticoagulants; Endoscopia; Endoscopy; Gastrointestinal bleeding; Hemorragia digestiva; Oral anticoagulation.